These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25200689)

  • 1. The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion.
    Keskin U; Ulubay M; Dede M; Ozgurtas T; Koçyiğit YK; Aydin FN; Ergün A
    Arch Gynecol Obstet; 2015 Mar; 291(3):557-61. PubMed ID: 25200689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
    Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
    Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum placental growth factor, vascular endothelial growth factor, soluble vascular endothelial growth factor receptor-1 and -2 levels in periodontal disease, and adverse pregnancy outcomes.
    Sert T; Kırzıoğlu FY; Fentoğlu O; Aylak F; Mungan T
    J Periodontol; 2011 Dec; 82(12):1735-48. PubMed ID: 21513467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women.
    Patrelli TS; Gizzo S; Plebani M; Basso D; Capobianco G; Bartolucci C; Modena AB; Rondinelli M; Nardelli GB
    Clin Exp Obstet Gynecol; 2012; 39(1):57-64. PubMed ID: 22675957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
    Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
    Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
    Moe K; Heidecke H; Dechend R; Staff AC
    Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maternal serum concentration of angiogenic factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction].
    Semczuk-Sikora A; Krzyzanowski A; Stachowicz N; Robak J; Kraczkowski J; Kwiatek M; Semczuk M
    Ginekol Pol; 2007 Oct; 78(10):783-6. PubMed ID: 18200969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.
    Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S
    Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.
    Palm M; Basu S; Larsson A; Wernroth L; Åkerud H; Axelsson O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1244-51. PubMed ID: 21568945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
    Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
    Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development.
    Kalamatianos T; Stavrinou LC; Koutsarnakis C; Psachoulia C; Sakas DE; Stranjalis G
    J Neurosurg; 2013 Feb; 118(2):353-7. PubMed ID: 23140147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
    Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
    Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.